Abstract
References
Articles referenced by this article (45)
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo.
Biochim Biophys Acta, (1):29-36 1991
MED: 2065067
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes.
FEBS Lett, (1):235-237 1990
MED: 2384160
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.
Proc Natl Acad Sci U S A, (24):11460-11464 1991
MED: 1763060
Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles.
Biochim Biophys Acta, (1):77-82 1991
MED: 1998713
Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times.
Biochim Biophys Acta, (1):187-192 1991
MED: 1751525
Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity.
Biochim Biophys Acta, (1):11-20 1994
MED: 7918551
Accelerated clearance of PEGylated liposomes in rats after repeated injections.
J Control Release, (1):35-42 2003
MED: 12586501
Accelerated clearance of a second injection of PEGylated liposomes in mice.
Int J Pharm, (1-2):167-174 2003
MED: 12672612
Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes.
J Pharmacol Exp Ther, (3):1071-1079 2000
MED: 10688625
Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection.
J Pharmacol Exp Ther, (2):607-612 2001
MED: 11454922
Show 10 more references (10 of 45)
Citations & impact
Impact metrics
Article citations
Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach.
J Nanobiotechnology, 22(1):710, 14 Nov 2024
Cited by: 0 articles | PMID: 39543630 | PMCID: PMC11566655
Review Free full text in Europe PMC
A Stealthiness Evaluation of Main Chain Carboxybetaine Polymer Modified into Liposome.
Pharmaceutics, 16(10):1271, 28 Sep 2024
Cited by: 0 articles | PMID: 39458603 | PMCID: PMC11510557
Polyesters and Polyester Nano- and Microcarriers for Drug Delivery.
Polymers (Basel), 16(17):2503, 03 Sep 2024
Cited by: 0 articles | PMID: 39274136 | PMCID: PMC11397835
Review Free full text in Europe PMC
Nanoparticle-Based Drug Delivery Systems for Inflammatory Bowel Disease Treatment.
Drug Des Devel Ther, 18:2921-2949, 15 Jul 2024
Cited by: 1 article | PMID: 39055164 | PMCID: PMC11269238
Review Free full text in Europe PMC
Nanoliposomes as nonviral vectors in cancer gene therapy.
MedComm (2020), 5(7):e583, 25 Jun 2024
Cited by: 1 article | PMID: 38919334 | PMCID: PMC11199024
Review Free full text in Europe PMC
Go to all (166) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes.
Int J Pharm, 392(1-2):218-223, 21 Mar 2010
Cited by: 66 articles | PMID: 20227473
Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon.
Immunobiology, 218(5):725-732, 23 Aug 2012
Cited by: 33 articles | PMID: 22995937
Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes.
J Control Release, 119(2):236-244, 24 Feb 2007
Cited by: 178 articles | PMID: 17399838
Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes.
Int J Pharm, 354(1-2):56-62, 09 Nov 2007
Cited by: 180 articles | PMID: 18083313
Review